Health Canada grants authorisation to Pfizer’s Paxlovid for Covid-19
The authorised dosage is two tablets of nirmatrelvir and one tablet of ritonavir given orally twice daily for five days.
North America
Latest in
North America
Partner content
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
After visiting 100 potential sites across eight different states, nutraceutical company Thorne HealthTech began a huge relocation to Charleston, South…
Canada to procure GSK’s Covid-19 antibody therapy doses
In October last year, GSK signed purchase agreement with Canada to supply 10,000 doses of Sotrovimab.
Pfizer and BioNTech enter deal to develop first mRNA vaccine for shingles
Pfizer will pay BioNTech $225m in an upfront payment, which includes a cash payment of $75m and an equity investment…
Twist-Revelar’s therapy neutralises Omicron and Delta variants
Revelar is concluding the preclinical and CMC development of RBT-0813 to start human trials shortly.
NRx Pharmaceuticals seeks FDA EUA for Zyesami to treat Covid-19
Last year, the FDA declined to grant EUA for Zyesami to treat individuals with critical Covid-19 having respiratory failure.
J&J agrees to pay $63m to settle opioid claims in Nevada
With the agreement announced by Nevada Attorney General Aaron Ford, the company is no longer involved in the opioid litigation.
Biogen to obtain licence for Ionis’ investigational SMA therapy
Biogen will handle the expenses associated with the development, production and potential marketing of BIIB115.